Table 1.
Summary of MS acquisition methods DDA, DIA, and MRM/PRM with respect to precursor selection, precision of detection and quantification, reproducibility and PTM analysis.
Meth od |
Precur sor selecti on |
Fragme nt- ation |
Collision method |
Detectio n |
Precision of peptide quantificati on |
Reproducibilit y of peptide identification |
Analysis (software) |
PTM localization |
Validation of PTM |
---|---|---|---|---|---|---|---|---|---|
DDA | Single | Single parent mass of the compound | CID, HCD, ETD, CAD51 | All fragments ions26 | Low/Moderate for spectra counts26 | Low: missing peptides across multiple runs26 | Multiple, straightforward178 | CID: neutral loss ETD: multistage activation HCD: fragment ions |
Predominant method with ETD fragmentation 15,179 |
DIA | Multiple | All peptides in a given m/z window | Alternating low-energy CID and high-energy CID51 | All fragments ions29 | Accurate: similar to MRM but more vulnerable to variation caused by interference from other peptides29 | Moderate: ~80% peptide overlap across multiple runs180 | Complex and requires deconvolution180,181 | CID: neutral loss | Complex182 |
MRM | Single | Single parent mass of the compound | HCD51 | High: Selection and detection of single fragment ion 29 | Precise183 | High38 | Multiple, straightforward 184 | MS2 fragmentation analysis185 | Rely on synthetic unlabeled and stable isotope-labeled peptides80 |
PRM | Single of multiple | Single parent mass of the compound | CID HCD |
All fragment ions | High: Run-to run peptide identification at the upper 85%39 | High186 | Multiple, straightforward | multistage activation fragmentation187 | Useful to study PTMs that are low in abundance188 |